Material-driven fibronectin and vitronectin assembly enhances BMP-2 presentation and osteogenesis
Source abstract
Abstract
Mesenchymal stem cell (MSC)-based tissue engineering strategies are of interest in the field of bone tissue regenerative medicine. MSCs are commonly investigated in combination with growth factors (GFs) and biomaterials to provide a regenerative environment for the cells. However, optimizing how biomaterials interact with MSCs and efficiently deliver GFs, remains a challenge. Here, via plasma polymerization, tissue culture plates are coated with a layer of poly (ethyl acrylate) (PEA), which is able to spontaneously permit fibronectin (FN) to form fibrillar nanonetworks. However, vitronectin (VN), another important extracellular matrix (ECM) protein forms multimeric globules on the polymer, thus not displaying functional groups to cells. Interestingly, when FN and VN are co-absorbed onto PEA surfaces, VN can be entrapped within the FN fibrillar nanonetwork in the monomeric form providing a heterogeneous, open ECM network. The combination of FN and VN promote MSC adhesion and leads to enhanced GF binding; here we demonstrate this with bone morphogenetic protein-2 (BMP2). Moreover, MSC differentiation into osteoblasts is enhanced, with elevated expression of osteopontin (OPN) and osteocalcin (OCN) quantified by immunostaining, and increased mineralization observed by von Kossa staining. Osteogenic intracellular signalling is also induced, with increased activity in the SMAD pathway. The study emphasizes the need of recapitulating the complexity of native ECM to achieve optimal cell-material interactions.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Cellular Mechanics and Interactions · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. An engineered biomimetic peptide regulates cell behavior by synergistic integrin and growth factor signaling
2. Extracellular matrix-based materials for regenerative medicine10.1038/s41578-018-0023-x ↗
3. Matrix enhance tissue healing
4. Mechanotransduction and growth factor signalling to engineer cellular microenvironments10.1002/adhm.201700052 ↗
5. Integrins as biomechanical sensors of the microenvironment10.1038/s41580-019-0134-2 ↗
6. The extracellular matrix: not just pretty fibrils10.1126/science.1176009 ↗
7. Receptor control in mesenchymal stem cell engineering10.1038/natrevmats.2017.91 ↗
8. Mecham · 2011
9. Designing stem cell niches for differentiation and self-renewal10.1098/rsif.2018.0388 ↗
10. Fibronectin activity on substrates with controlled - OH density10.1002/jbm.a.32374 ↗
11. Role of material-driven fibronectin fibrillogenesis in cell differentiation10.1016/j.biomaterials.2010.11.057 ↗
12. Engineered microenvironments for synergistic VEGF – integrin signalling during vascularization10.1016/j.biomaterials.2017.02.024 ↗
13. Nanoscale coatings for ultralow dose BMP-2-driven regeneration of critical-sized bone defects
14. Material-driven fibronectin assembly for high-efficiency presentation of growth factors10.1126/sciadv.1600188 ↗
15. Vitronectin - master controller or micromanager?10.1002/iub.1203 ↗
16. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 110.1083/jcb.130.3.503 ↗
17. Dynamic behavior of vitronectin at the cell-material interface10.1021/acsbiomaterials.5b00147 ↗
18. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells10.1042/bj3070867 ↗
19. Vitronectin and its receptors10.1016/0955-0674(93)90036-P ↗
20. Su · 2018
21. Clustering of α5β1 integrins determines adhesion strength whereas αvβ3 and talin enable mechanotransduction10.1073/pnas.0902818106 ↗
22. Integrin dynamics and matrix assembly: tensin-dependent translocation of α5β1 integrins promotes early fibronectin fibrillogenesis10.1083/jcb.148.5.1075 ↗
23. Vitronectin as a micromanager of cell response in material-driven fibronectin nanonetworks10.1002/adbi.201700047 ↗
24. Vitronectin alters fibronectin organization at the cell-material interface10.1016/j.colsurfb.2013.07.016 ↗
25. Vitronectin activity on polymer substrates with controlled -OH density10.1016/j.polymer.2010.03.041 ↗
26. Plasma polymerised nanoscale coatings of controlled thickness for efficient solid-phase presentation of growth factors10.1016/j.msec.2020.110966 ↗
27. Bone morphogenetic proteins in fracture repair10.1007/s00264-018-4153-y ↗
28. Application of bone morphogenetic proteins in spinal fusion10.1016/j.cytogfr.2005.02.004 ↗
29. Step-by-step quantitative analysis of focal adhesions10.1016/j.mex.2014.06.004 ↗
30. High resolution XPS of organic polymers: the Scienta ESCA300 database10.1016/0368-2048(93)85006-7 ↗
31. Functionalization of PLLA with polymer brushes to trigger the assembly of fibronectin into nanonetworks
32. Sterilization and disinfection of biomaterials for medical devices10.1016/B978-0-12-816137-1.00091-X ↗
33. Fibronectin at a glance10.1242/jcs.00059 ↗
34. The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain
35. Nanoscale architecture of integrin-based cell adhesions10.1038/nature09621 ↗
36. Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand10.1126/science.1069040 ↗
37. Structure of integrin α5β1 in complex with fibronectin10.1093/emboj/cdg445 ↗
38. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype10.1359/jbmr.060109 ↗
39. Functional polymer surfaces for controlling cell behaviors10.1016/j.mattod.2017.07.002 ↗
40. Insight into vitronectin structural evolution on material surface chemistries: the mediation for cell adhesion
41. Adsorption force of fibronectin on various surface chemistries and its vital role in osteoblast adhesion10.1021/bm501873g ↗
42. The correlation between the adsorption of adhesive proteins and cell behaviour on hydroxyl-methyl mixed self-assembled monolayers10.1016/j.biomaterials.2008.09.048 ↗
43. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion10.1002/jbm.a.10537 ↗
44. 2011
45. The fibronectin-binding integrins α5β1 and αvβ3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis10.1083/jcb.200205014 ↗
46. Giving off mixed signals - distinct functions of α5β 1 and αvβ3 integrins in regulating cell behaviour10.1002/iub.200 ↗
47. Interactions between growth factor receptors and adhesion molecules: breaking the rules10.1016/S0955-0674(03)00096-6 ↗
48. Surface Co-presentation of BMP-2 and integrin selective ligands at the nanoscale favors α5β1 integrin-mediated adhesion10.1016/j.biomaterials.2020.120484 ↗
49. β3 integrin-mediated spreading induced by matrix-bound BMP-2 controls Smad signaling in a stiffness-independent manner10.1083/jcb.201508018 ↗
50. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity10.1242/jcs.031286 ↗
51. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing10.1126/scitranslmed.3002614 ↗
52. Extracellular matrix-inspired growth factor delivery systems for bone regeneration10.1016/j.addr.2015.04.007 ↗
53. Engineering growth factors for regenerative medicine applications10.1016/j.actbio.2015.11.007 ↗
54. FAK integrates growth-factor and integrin signals to promote cell migration10.1038/35010517 ↗
55. Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins10.1038/35023515 ↗
56. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review10.3310/hta11300 ↗
57. Adverse events reported after the use of recombinant human bone morphogenetic protein 210.1016/j.joms.2011.09.008 ↗
58. Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures general10.1007/s11999-012-2684-x ↗
59. Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database10.1016/j.spinee.2012.09.052 ↗
60. Improving the osteogenic potential of BMP-2 with hyaluronic acid hydrogel modified with integrin-specific fibronectin fragment10.1016/j.biomaterials.2012.10.015 ↗
61. Harnessing endogenous growth factor activity modulates stem cell behavior10.1039/c1ib00021g ↗
62. Presentation of BMP-2 from a soft biopolymeric film unveils its activity on cell adhesion and migration